Methods for treating hypophosphatemic disorders
US10639360B2 · kind B2 · utility
3Cited by
12References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2015 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | May 29, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.